UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of allergy and clinical immunology, ISSN 0091-6749, 08/2019, Volume 144, Issue 2, pp. 381 - 392
angioedema | anaphylaxis | urticaria | Drug allergy | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Hypersensitivity, Delayed - pathology | Angioedema - pathology | Humans | Urticaria - pathology | Anaphylaxis - therapy | Urticaria - immunology | Hypersensitivity, Delayed - therapy | Angioedema - immunology | Hypersensitivity, Delayed - immunology | Drug Hypersensitivity - therapy | Urticaria - therapy | Drug Hypersensitivity - pathology | Anaphylaxis - chemically induced | Angioedema - therapy | Drug Hypersensitivity - immunology | Hypersensitivity, Delayed - chemically induced | Urticaria - chemically induced | Anaphylaxis - immunology | Quality of Life | beta-Lactams - adverse effects | Angioedema - chemically induced | beta-Lactams - therapeutic use | Epinephrine | Tyrosine | Drug resistance in microorganisms | C-reactive protein | Medical societies | Medical records | Epidemiology | Angioneurotic edema | Anaphylaxis | Algorithms | Beta lactamases | Drug therapy | Pediatrics | Hypersensitivity (delayed) | Pathogenesis | Clinical trials | Amides | Pruritus | Dermatitis | Antibiotic resistance | Penicillin | Hospital costs | β-Lactam antibiotics | Urticaria | Mortality | Angioedema | Hypersensitivity | Cloning | Staphylococcus infections | Patients | Quality of life | Studies | Prescription drugs | Health care expenditures | Antibiotics | MicroRNAs | Biomarkers | Index Medicus | Abridged Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2015, Volume 136, Issue 2, pp. 245 - 251
Allergy and Immunology | nonsteroidal anti-inflammatory drugs | angioedema | Aspirin | urticaria | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Drug Hypersensitivity - etiology | Humans | Drug Hypersensitivity - drug therapy | Angioedema - immunology | Angioedema - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Time Factors | Aspirin - adverse effects | Drug Hypersensitivity - immunology | Drug Hypersensitivity - diagnosis | Angioedema - chemically induced | Angioedema - diagnosis | Disease Management | Cyclooxygenase Inhibitors - therapeutic use | Skin - drug effects | Skin - pathology | Desensitization, Immunologic - methods | Skin - immunology | COX-2 inhibitors | Medical colleges | Angioneurotic edema | Diagnosis | Drug therapy | Enzymes | Acids | Pathogenesis | Classification | Nonsteroidal anti-inflammatory drugs | Kinases | Drug dosages | Patients | Allergies | Asthma | Chronic illnesses | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2008, Volume 358, Issue 15, pp. 1547 - 1559
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Male | Risk | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Double-Blind Method | Diabetes Mellitus - drug therapy | Kaplan-Meier Estimate | Hospitalization | Creatinine - blood | Angioedema - chemically induced | Aged | Complications and side effects | Ramipril | Drug therapy, Combination | Diabetes | Cardiovascular diseases | Drug therapy | Comparative analysis | Risk factors | Telmisartan | Clinical trials | Vein & artery diseases | Cardiovascular disease | Pharmacology | Clinical outcomes | Index Medicus | Abridged Index Medicus | Blood Pressure | Benzimidazoles | Cardiovascular Diseases | MEDICIN OCH HÄLSOVETENSKAP | Angiotensin II Type 1 Receptor Blockers | epidemiology | Angiotensin-Converting Enzyme Inhibitors | Combination | MEDICAL AND HEALTH SCIENCES | Creatinine | chemically induced | Benzoates | drug therapy | Angioedema | drug effects | Diabetes Mellitus | blood | adverse effects | mortality | therapeutic use | Kaplan-Meiers Estimate
Journal Article
Drug design, development and therapy, ISSN 1177-8881, 02/2014, Volume 8, pp. 197 - 207
Mastocytosis | Anaphylaxis | Anti-IgE | Atopic dermatitis | Urticaria | Hypersensitivity | Immunoglobulin E | Omalizumab | Asthma | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Off-Label Use | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Skin Diseases - drug therapy | Food Hypersensitivity - drug therapy | Nasal Polyps - drug therapy | Antibodies, Anti-Idiotypic - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Asthma - drug therapy | Rhinitis, Allergic - drug therapy | Pharmaceutical research | Physiological aspects | Research | Drug therapy | Allergens | Disease | Rhinitis | Disorders | Clinical trials | Antibodies | Effector cells | Allergic bronchopulmonary aspergillosis | Dermatitis | Marketing | Immunotherapy | Drug dosages | Economics | Immunoglobulins | Angioedema | Pharmacology | Polyposis | Patients | Latex | Allergies | Aspergillosis | Monoclonal antibodies | Index Medicus | anti-IgE | hypersensitivity | mastocytosis | urticaria | atopic dermatitis | omalizumab | asthma | anaphylaxis | immunoglobulin E
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 11/2010, Volume 104, Issue 5, pp. 886 - 893
kallikrein-kinin system | C1 inhibitor | ischaemia | complement | sepsis | Reperfusion injury | Theme Issue Article | Sepsis | Complement | Kallikrein-kinin system | Ischaemia- reperfusion injury | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Biological and medical sciences | Blood coagulation. Blood cells | Molecular and cellular biology | Medical sciences | Platelet diseases and coagulopathies | Complement C1 Inhibitor Protein - therapeutic use | Capillary Permeability | Complement Activation | Humans | Reperfusion Injury - drug therapy | Structure-Activity Relationship | Shock, Septic - immunology | Reperfusion Injury - blood | Sepsis - drug therapy | Hemostasis | Shock, Septic - blood | Shock, Septic - drug therapy | Anti-Inflammatory Agents - therapeutic use | Angioedemas, Hereditary - drug therapy | Complement C1 Inhibitor Protein - metabolism | Angioedemas, Hereditary - blood | Graft Rejection - drug therapy | Sepsis - immunology | Signal Transduction | Malaria - immunology | Complement C1 Inhibitor Protein - genetics | Complement C1 Inhibitor Protein - chemistry | Angioedemas, Hereditary - immunology | Animals | Reperfusion Injury - immunology | Protein Conformation | Sepsis - blood | Graft Rejection - immunology | Malaria - drug therapy | Graft Rejection - blood | Malaria - blood
Journal Article
Future medicinal chemistry, ISSN 1756-8919, 08/2012, Volume 4, Issue 12, pp. 1527 - 1531
Journal Article
eLife, ISSN 2050-084X, 2020, Volume 9
Biology | Life Sciences & Biomedicine - Other Topics | Life Sciences & Biomedicine | Science & Technology | Inflammation - pathology | Pandemics | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Angioedema - metabolism | COVID-19 | Pneumonia, Viral - metabolism | Respiratory Distress Syndrome - prevention & control | SARS-CoV-2 | Coronavirus Infections - metabolism | Betacoronavirus - physiology | Anti-Inflammatory Agents - therapeutic use | Respiratory Distress Syndrome - drug therapy | Lung - metabolism | Kinins - metabolism | Lung - pathology | Angioedema - pathology | Signal Transduction | Antiviral Agents - therapeutic use | Endothelial Cells - metabolism | Pneumonia, Viral - pathology | Inflammation - immunology | Respiratory Distress Syndrome - pathology | Angioedema - drug therapy | Coronavirus Infections - pathology | Receptor, Bradykinin B2 - metabolism | Receptor, Bradykinin B1 - metabolism | Drug Development | Endothelial Cells - pathology | Bradykinin Receptor Antagonists - therapeutic use | Kallikreins - metabolism | Plasma | Ventilators | Edema | Pathogenesis | Angioedema | Lung diseases | Kallikrein | Inflammation | Permeability | Coronaviruses | Anti-inflammatory agents | Endothelial cells | Severe acute respiratory syndrome coronavirus 2 | Dyspnea | Respiratory distress syndrome | Influenza | Bradykinin | Plasma kallikrein | Ligands | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 04/2017, Volume 129, Issue 16, pp. 2280 - 2290
Life Sciences & Biomedicine | Hematology | Science & Technology | Plasma Kallikrein - metabolism | Humans | Male | Cerebral Hemorrhage - genetics | Stroke - genetics | Tissue Plasminogen Activator - adverse effects | Cerebral Hemorrhage - blood | Stroke - pathology | Fibrinolytic Agents - adverse effects | Plasma Kallikrein - genetics | Matrix Metalloproteinase 9 - metabolism | Matrix Metalloproteinase 9 - genetics | Infarction, Middle Cerebral Artery - genetics | Infarction, Middle Cerebral Artery - drug therapy | Thrombosis - blood | Disease Models, Animal | Cerebral Hemorrhage - chemically induced | Gene Expression | Factor XII - genetics | Stroke - drug therapy | Infarction, Middle Cerebral Artery - pathology | Angioedema - genetics | Infarction, Middle Cerebral Artery - blood | Mice, Knockout | Stroke - blood | Thrombosis - pathology | Administration, Intravenous | Animals | Angioedema - blood | Factor XII - metabolism | Thrombolytic Therapy | Angioedema - chemically induced | Thrombosis - genetics | Mice | Thrombosis - drug therapy | Index Medicus | Abridged Index Medicus | Thrombosis and Hemostasis
Journal Article